Rotational atherectomy is only an interim strategy.

Original title: High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary Lesions. The Randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) Trial. Reference: Mohamed Abdel-Wahab et al. J Am Coll Cardiol Intv 2013; article in press

Heavily calcified lesions are difficult and may prevent the appropriate expansion of a drug-eluting stent (DES) with consequent increased risk of thrombosis and/or restenosis. 

Besides this type of injury may also damage the DES polymer and produce an inadequate diffusion of the drug to the subintimal. Rotational atherectomy, (RA), can effectively ablate these plates which could improve the effectiveness of a DES in this context. 

Rotablator was used (Boston Scientific Scimed, Maple Grove, Minnesota) with a chosen size of catheter to achieve a relationship with the size of the vessel 0.5. The primary endpoint was late lumen loss at nine months of angiographic follow-up. 240 patients were randomized with de novo lesions and moderate to severe calcification and Taxus versus rotational atherectomy and Taxus. 

The clinical and angiographic characteristics were well balanced between the groups. Making an analysis by treatment intention, angiographic success was identical, (96.7%), but considering that 12.5% of randomized patients to standard dilation finally received RA, the ultimate results achieved was significantly better for RA (92.5% versus 83.3%, P = 0.03). 

A 9 month follow-up of cardiac events (MACE) was similar in both groups, (24.2% versus standard. RA 28.3%, P = 0.46), as well as late lumen loss (primary endpoint) with 0.31 ± 0.52 mm versus standard group and 0.44 ± 0.58 mm for RA (p = 0.04).

Conclusion 

In this study routine rotational atherectomy prior to Taxus stent implantation in calcified lesions was not superior to Taxus stent implantation only.

Editorial Comment:

ROTAXUS is the first randomized, controlled trial testing routine rotational atherectomy prior to DES and probably evaluated a population with more complex anatomy which has been included in the job with stents. Considering the results, the high volume at centers and the great experience of the surgeons involved, we would say that the use of rotational atherectomy is just a rescue strategy. However, the “standard strategy” was to dilate to high atmospheres using not self-righteous balloons. Despite this, there was a high crossover. While it is true that rotational atherectomy does not improve performance in monitoring, it does change impatient procedure success in this type of injury.

SOLACI.ORG

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...